AssetMark’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
AssetMark's PRCT Position: Q3 2026 in Review
AssetMark reduced its Procept Biorobotics (PRCT) stake by 11% in Q3 2026, selling an estimated $65.9K and leaving 27,519 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.
AssetMark first reported a position in PRCT in Q4 2024 and has held it in 8 quarters since. The position peaked at $696K in Q2 2026. 174 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- AssetMark held 27,519 shares of Procept Biorobotics worth $501K as of Q3 2026.
- AssetMark sold 3,306 Procept Biorobotics shares in Q3 2026, an estimated $65.9K.
- Procept Biorobotics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1250 holding.
- AssetMark first reported a position in Procept Biorobotics in Q4 2024 and has held it in 8 quarters since.
- AssetMark's Procept Biorobotics position peaked at $696K in Q2 2026.
- 174 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.